Richard C. Henriques Jr.

Filings by Richard C. Henriques Jr. span 2 companies, the busiest being Merck & Co., Inc. and Arbutus Biopharma Corp. Between 6 February 2006 and 24 August 2015, the trades on record add up to 5 filings.

Market trades split into 1 purchase (€6,000) and 3 sales (€716k). The net balance comes to €710k on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 1 option exercise. So far in 2015, the count stands at 1 purchase and no sales.

The newest entry dates from 26 August 2015: an open-market purchase of €6,000, in Arbutus Biopharma Corp. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.